Published May 23, 2019
| Version v1
Patent
Open
BTK MUTATION AND IBRUTINIB RESISTANCE
Contributors
Patent applicant:
Description
Provided herein are mutations in Bruton's Tyrosine Kinase (BTK) that confer resistance to treatment with a BTK inhibitors, such as Ibrutinib, and compositions and methods for the treatment, diagnosis, and characterization of BTK-inhibitor-resistant cancers.
Files
US20190153543.pdf
Files
(1.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ebf62523223ce440b56ea9bc898d7eab
|
1.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201716302015 A
- Patent number
- US 2019/0153543 A1
- Other
- oai:uchicago.tind.io:8164
Dates
- Patent filed
-
2017-05-18